Results 181 to 190 of about 101,012 (310)

Seed localization in eye plaque brachytherapy [PDF]

, 1998
Richard Emery, A. Szechter
openalex   +1 more source

Radiotherapy dose prediction using off‐the‐shelf segmentation networks: A feasibility study with GammaPod planning

Medical Physics, Volume 52, Issue 5, Page 3348-3359, May 2025.
Abstract Background Radiotherapy requires precise, patient‐specific treatment planning to achieve high‐quality dose distributions that improve patient outcomes. Traditional manual planning is time‐consuming and clinically impractical for performing necessary plan trade‐off comparisons, including treatment modality selection, prescription dose settings,
Qingying Wang, Mingli Chen, Mahdieh Kazemimoghadam, Zi Yang, Kangning Zhang, Xuejun Gu, Weiguo Lu   +6 more
wiley   +1 more source

Brachytherapy in the treatment of cervical cancer: a review

International Journal of Women's Health, 2014
Robyn Banerjee,1 Mitchell Kamrava21Department of Radiation Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada; 2Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USAAbstract: Dramatic advances have been ...
Banerjee R, Kamrava M
doaj  

Rapid two-dimensional dose measurement in brachytherapy using plastic scintillator sheet: linearity, signal-to-noise ratio, and energy response characteristics

, 1992
H Perera, Jeffrey F. Williamson, Suzanne P. Monthofer, W. R. Binns, J. Klarmann, Gary L. Fuller, John Wong   +6 more
openalex   +1 more source

Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial [PDF]

, 1996
William A. See, Robert Dreicer, James A. Wheeler, Paula K. Forest, Stefan A. Loening   +4 more
openalex   +2 more sources

The Safety and Efficacy of Targeted Alpha Therapy, Ac‐225 Prostate‐Specific Membrane Antigen, in Patients With Metastatic Castration‐Resistant Prostate Cancer: A Systematic Review and Meta‐Analysis

The Prostate, Volume 85, Issue 6, Page 541-557, May 2025.
ABSTRACT Background Metastatic castration resistance prostate cancer (mCRPC) is a challenging disease with a significant burden of mortality and morbidity. Most of the patients attain resistance to the available treatments, necessitating further novel therapies in this clinical setting.
Huseyin Besiroglu, Mustafa Kadihasanoglu
wiley   +1 more source

Fractionated high-dose rate brachytherapy for intracranial gliomas

, 1994
Shiao Y. Woo, E. Brian Butler, Walter H. Grant, Barry Berner, Philip L. Gildenberg   +4 more
openalex   +1 more source

Translation, Cross‐Cultural Adaptation, and Psychometric Validation of the Turkish Version of the “Expanded Prostate Cancer Index Composite (EPIC)” in Prostate Cancer Patients

The Prostate, Volume 85, Issue 7, Page 710-718, May 15, 2025.
ABSTRACT Purpose The Expanded Prostate Cancer Index Composite (EPIC) is a symptom scale that measures health‐related quality of life (HRQoL) in prostate cancer (PCa) patients. This scale is translated into different languages and used in daily practice.
Burak Tilki, Pervin Hurmuz, Deniz Yuce, Gokhan Ozyigit, Fadil Akyol   +4 more
wiley   +1 more source

High-dose-rate brachytherapy for cervical carcinoma

, 1992
Judith A. Stitt, Bruce Thomadsen, Jack F. Fowler   +2 more
openalex   +1 more source

Laser and brachytherapy in the palliation of adenocarcinoma of the oesophagus and cardia. [PDF]

, 1996
G M Spencer, Sally Thorpe, Ian Sargeant, Glen Blackman, J Solano, Jeffrey Tobias, Stephen G. Bown   +6 more
openalex   +1 more source